Glasdegib with LDAC in Newly Diagnosed Patients with Acute Myeloid Leukemia (AML) Unsuitable for Intensive Chemotherapy: Effects on Transfusions and Marrow Recovery vs LDAC Alone

Authors :: Weidong Wendy Ma
Eunice S. Wang
Ashleigh O'Connell
Caroline J. Hoang
Akil Merchant
Geoffrey Chan
Michael Heuser
James K. McCloskey
Olga Salamero
Carmen Pedro Olive
Jorge E. Cortes
Mikkael A. Sekeres
Mirjana Zeremski
Pau Montesinos
Source :: Clinical Lymphoma Myeloma and Leukemia. 19:S230
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Internal medicine
medicine
Myeloid leukemia
Hematology
Newly diagnosed
Intensive chemotherapy
business

Tools